Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
2.230
+0.050 (2.29%)
Jan 21, 2025, 4:00 PM EST - Market closed
Canopy Growth Revenue
Canopy Growth had revenue of 62.99M CAD in the quarter ending September 30, 2024, a decrease of -9.49%. This brings the company's revenue in the last twelve months to 280.50M, down -6.17% year-over-year. In the fiscal year ending March 31, 2024, Canopy Growth had annual revenue of 297.15M, down -10.83%.
Revenue (ttm)
280.50M CAD
Revenue Growth
-6.17%
P/S Ratio
n/a
Revenue / Employee
272,591 CAD
Employees
1,029
Market Cap
272.20M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
CGC News
- 4 days ago - Canadian Marijuana Stocks To Watch To Close Out The Week - MarijuanaStocks
- 14 days ago - Top Canadian Cannabis Stocks to Watch for Breakout Opportunities in 2025 - MarijuanaStocks
- 15 days ago - Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President - PRNewsWire
- 23 days ago - Top Canadian Marijuana Stocks For Your 2025 Watchlist - MarijuanaStocks
- 25 days ago - Cannabis sector limps into 2025 because ‘the gold rush is over' - Market Watch
- 4 weeks ago - Top Marijuana Stocks For Investors 2025 - MarijuanaStocks
- 5 weeks ago - STORZ & BICKEL Makes History as First Vaporizer Brand to Sponsor NYLON House During Miami Art Week - PRNewsWire
- 6 weeks ago - Canopy Growth and Acreage Confirm Canopy USA's Completed Acquisition of Acreage - PRNewsWire